FDA Inspection
Agnesian Healthcare IRBAgnesian Healthcare IRB – FDA Inspection, Jun 17, 2014
Record Details
This FDA Inspection record concerns Agnesian Healthcare IRB, with an inspection on June 17, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Agnesian Healthcare IRB
- Inspection Date
- June 17, 2014
- Product Type
- Drugs
View Company Profile
ID · c956da3d-c367-4420-baa8-eca74cc51d16
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 884359
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 56.115(a)(4)Copies of IRB/CI correspondence
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.109(e)IRB approvals/disapprovals - general
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Agnesian Healthcare IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2018 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| November 13, 2012 | OAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Agnesian Healthcare IRB
- FDA Inspection 1071800 - 2018-11-05
- FDA Inspection 807438 - 2012-11-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.